In support of this view, analysis of survival data from the Genomics Data Commons (GDC) portal (Grossman et al, 2016) revealed that low levels of FBXW7 expression significantly correlated with poor survival in cancer patients undergoing any type of therapy (Appendix Fig S2F and G). The gene discussed is FBXW7; the disease is cancer.